Reduced-intensity umbilical cord blood transplant for older adult patients

Bone Marrow Transplantation

Volumn 42, Issue 10, 2008, Pages 685-686

  Lim, S H ^a,b   Esler, W V ^a,b   Periman, P O ^a,b   Beggs, D ^a,b   Zhang, Y ^a,b   Townsend, M ^a,b  

^a Biotherapy and Stem Cell Transplant Program   (United States)

^b Harrington Regional Medical Center Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; FLUDARABINE; MELPHALAN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COMORBIDITY; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE TRANSFUSION; UMBILICAL CORD BLOOD;

ADULT; AGE FACTORS; AGED; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 57049164251     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.225     Document Type: Article

References (6)

1. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang M, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-2275.
2. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al Transplants of umbilical-cord blood or bone marrow from unrelated donors in adult with acute leukemia. N Engl J Med 2004; 351: 2276-2285.
3. Gardiner CM, Carver J, Abraham BL, Wilson JB, Huisman TH. Differential cytotoxicity of cord blood and bone marrow derived natural killer cells. Blood 1998; 91: 207-213.
4. Haut PR, Gonzalez-Ryan L, Wang LJ, Olszewski M, Morgan E, Kletzel M. Induction of a transient graft vs leukemia effect following unrelated cord blood transplantation. Pediatr Transplant 2002; 6: 348-351.
5. Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Miller JS, AroraM et al. Reduced-intensity allogeneic transplant in patients older than 55 years: Unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 2008; 14: 282-289.
6. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al Hematopoietic cell transplantation (HCT)-specific comorbidity index: anew tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912-2919.